Literature DB >> 25637275

The genetics of splicing in neuroblastoma.

Justin Chen1, Christopher S Hackett2, Shile Zhang3, Young K Song4, Robert J A Bell5, Annette M Molinaro6, David A Quigley7, Allan Balmain8, Jun S Song9, Joseph F Costello8, W Clay Gustafson10, Terry Van Dyke11, Pui-Yan Kwok12, Javed Khan4, William A Weiss13.   

Abstract

UNLABELLED: Regulation of mRNA splicing, a critical and tightly regulated cellular function, underlies the majority of proteomic diversity and is frequently disrupted in disease. Using an integrative genomics approach, we combined both genomic data and exon-level transcriptome data in two somatic tissues (cerebella and peripheral ganglia) from a transgenic mouse model of neuroblastoma, a tumor that arises from the peripheral neural crest. Here, we describe splicing quantitative trait loci associated with differential splicing across the genome that we use to identify genes with previously unknown functions within the splicing pathway and to define de novo intronic splicing motifs that influence splicing from hundreds of bases away. Our results show that these splicing motifs represent sites for functional recurrent mutations and highlight novel candidate genes in human cancers, including childhood neuroblastoma. SIGNIFICANCE: Somatic mutations with predictable downstream effects are largely relegated to coding regions, which comprise less than 2% of the human genome. Using an unbiased in vivo analysis of a mouse model of neuroblastoma, we have identified intronic splicing motifs that translate into sites for recurrent somatic mutations in human cancers. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25637275      PMCID: PMC4390477          DOI: 10.1158/2159-8290.CD-14-0892

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  54 in total

1.  Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes.

Authors:  Jan J Molenaar; Jan Koster; Danny A Zwijnenburg; Peter van Sluis; Linda J Valentijn; Ida van der Ploeg; Mohamed Hamdi; Johan van Nes; Bart A Westerman; Jennemiek van Arkel; Marli E Ebus; Franciska Haneveld; Arjan Lakeman; Linda Schild; Piet Molenaar; Peter Stroeken; Max M van Noesel; Ingrid Ora; Evan E Santo; Huib N Caron; Ellen M Westerhout; Rogier Versteeg
Journal:  Nature       Date:  2012-02-22       Impact factor: 49.962

2.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks.

Authors:  Cole Trapnell; Adam Roberts; Loyal Goff; Geo Pertea; Daehwan Kim; David R Kelley; Harold Pimentel; Steven L Salzberg; John L Rinn; Lior Pachter
Journal:  Nat Protoc       Date:  2012-03-01       Impact factor: 13.491

3.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

4.  Association of age at diagnosis and genetic mutations in patients with neuroblastoma.

Authors:  Nai-Kong V Cheung; Jinghui Zhang; Charles Lu; Matthew Parker; Armita Bahrami; Satish K Tickoo; Adriana Heguy; Alberto S Pappo; Sara Federico; James Dalton; Irene Y Cheung; Li Ding; Robert Fulton; Jianmin Wang; Xiang Chen; Jared Becksfort; Jianrong Wu; Catherine A Billups; David Ellison; Elaine R Mardis; Richard K Wilson; James R Downing; Michael A Dyer
Journal:  JAMA       Date:  2012-03-14       Impact factor: 56.272

5.  Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.

Authors:  Kristopher R Bosse; Sharon J Diskin; Kristina A Cole; Andrew C Wood; Robert W Schnepp; Geoffrey Norris; Le B Nguyen; Jayanti Jagannathan; Michael Laquaglia; Cynthia Winter; Maura Diamond; Cuiping Hou; Edward F Attiyeh; Yael P Mosse; Vanessa Pineros; Eva Dizin; Yongqiang Zhang; Shahab Asgharzadeh; Robert C Seeger; Mario Capasso; Bruce R Pawel; Marcella Devoto; Hakon Hakonarson; Eric F Rappaport; Irmgard Irminger-Finger; John M Maris
Journal:  Cancer Res       Date:  2012-02-20       Impact factor: 12.701

6.  A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.

Authors:  Wei Ding; Qian Tang; Virginia Espina; Lance A Liotta; David T Mauger; Kathleen M Mulder
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

7.  Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data.

Authors:  Valentina Boeva; Tatiana Popova; Kevin Bleakley; Pierre Chiche; Julie Cappo; Gudrun Schleiermacher; Isabelle Janoueix-Lerosey; Olivier Delattre; Emmanuel Barillot
Journal:  Bioinformatics       Date:  2011-12-06       Impact factor: 6.937

8.  Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide II.

Authors:  Margaret A Schwarz; Janet Thornton; Haiming Xu; Niranjan Awasthi; Roderich E Schwarz
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

9.  Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution.

Authors:  Robert K Bradley; Jason Merkin; Nicole J Lambert; Christopher B Burge
Journal:  PLoS Biol       Date:  2012-01-03       Impact factor: 8.029

10.  Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes.

Authors:  Kerrin S Small; Asa K Hedman; Elin Grundberg; Alexandra C Nica; Gudmar Thorleifsson; Augustine Kong; Unnur Thorsteindottir; So-Youn Shin; Hannah B Richards; Nicole Soranzo; Kourosh R Ahmadi; Cecilia M Lindgren; Kari Stefansson; Emmanouil T Dermitzakis; Panos Deloukas; Timothy D Spector; Mark I McCarthy
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

View more
  12 in total

Review 1.  The master regulator FUBP1: its emerging role in normal cell function and malignant development.

Authors:  Lydie Debaize; Marie-Bérengère Troadec
Journal:  Cell Mol Life Sci       Date:  2018-10-20       Impact factor: 9.261

Review 2.  The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Authors:  Nancy Ratner; Garrett M Brodeur; Russell C Dale; Nina F Schor
Journal:  Ann Neurol       Date:  2016-04-30       Impact factor: 10.422

3.  Clonal evidence for the development of neuroblastoma with extensive copy-neutral loss of heterozygosity arising in a mature teratoma.

Authors:  Rintaro Ono; Hiroo Ueno; Kenichi Yoshida; Satoko Takahashi; Hiroki Yoshihara; Taiki Nozaki; Koyu Suzuki; Atsuko Nakazawa; Ryunosuke Saiki; Masafumi Seki; Junko Takita; Seishi Ogawa; Atsushi Manabe; Daisuke Hasegawa
Journal:  Cancer Sci       Date:  2021-05-06       Impact factor: 6.716

4.  Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.

Authors:  Jinsong Qiu; Bing Zhou; Felicitas Thol; Yu Zhou; Liang Chen; Changwei Shao; Christopher DeBoever; Jiayi Hou; Hairi Li; Anuhar Chaturvedi; Arnold Ganser; Rafael Bejar; Dong-Er Zhang; Xiang-Dong Fu; Michael Heuser
Journal:  RNA       Date:  2016-08-04       Impact factor: 4.942

5.  CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network.

Authors:  Bülent Arman Aksoy; Vlado Dancík; Kenneth Smith; Jessica N Mazerik; Zhou Ji; Benjamin Gross; Olga Nikolova; Nadia Jaber; Andrea Califano; Stuart L Schreiber; Daniela S Gerhard; Leandro C Hermida; Subhashini Jagu; Chris Sander; Aris Floratos; Paul A Clemons
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

6.  Whole exome sequencing reveals novel somatic alterations in neuroblastoma patients with chemotherapy.

Authors:  Chao Duan; Han Wang; Ying Chen; Ping Chu; Tianyu Xing; Chao Gao; Zhixia Yue; Jie Zheng; Mei Jin; Weiyue Gu; Xiaoli Ma
Journal:  Cancer Cell Int       Date:  2018-02-17       Impact factor: 5.722

7.  Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma.

Authors:  Jessica L Bell; Sven Hagemann; Jessica K Holien; Tao Liu; Zsuzsanna Nagy; Johannes H Schulte; Danny Misiak; Stefan Hüttelmaier
Journal:  Int J Mol Sci       Date:  2020-07-19       Impact factor: 5.923

8.  Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.

Authors:  Anton Ogorodnikov; Michal Levin; Surendra Tattikota; Sergey Tokalov; Mainul Hoque; Denise Scherzinger; Federico Marini; Ansgar Poetsch; Harald Binder; Stephan Macher-Göppinger; Hans Christian Probst; Bin Tian; Michael Schaefer; Karl J Lackner; Frank Westermann; Sven Danckwardt
Journal:  Nat Commun       Date:  2018-12-14       Impact factor: 14.919

9.  Increased plasma concentration of cell-free DNA precedes disease recurrence in children with high-risk neuroblastoma.

Authors:  Yan Su; Lijun Wang; Chiyi Jiang; Zhixia Yue; Hongjun Fan; Huimin Hong; Chao Duan; Mei Jin; Dawei Zhang; Lihua Qiu; Xianfeng Cheng; Zhong Xu; Xiaoli Ma
Journal:  BMC Cancer       Date:  2020-02-06       Impact factor: 4.430

Review 10.  Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.

Authors:  Neetha Nanoth Vellichirammal; Nagendra K Chaturvedi; Shantaram S Joshi; Donald W Coulter; Chittibabu Guda
Journal:  Cancer Lett       Date:  2020-11-25       Impact factor: 9.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.